Clovis Oncology (CLVS) Falls Further Behind

Clovis Oncology Inc CLVS shares fell 5.7% to $13.43 after dropping 5.4% on Tuesday. JP Morgan downgraded Clovis from overweight to neutral and lowered the price target from $42.00 to $15.00. Share volume was 4.3 million, compared to an all-day average of 1.3 million